1IA
PAHC icon

1620 Investment Advisors’s Phibro Animal Health PAHC Stock Holding History

1620 Investment Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3K Sell
550
-126
-19% -$5.32K 0.01% 435
2026
Q1 		$37.4K Hold
676
– – 0.03% 333
2025
Q4 		$25.3K Buy
676
+295
+77% +$12K 0.02% 371
2025
Q3 		$15.4K Buy
+381
New +$12.6K 0.01% 411

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

1620 Investment Advisors's PAHC Position: Q2 2026 in Review

1620 Investment Advisors reduced its Phibro Animal Health (PAHC) stake by 19% in Q2 2026, selling an estimated $5.32K and leaving 550 shares worth $17.3K. The position accounts for 0.01% of the portfolio, ranked #435.

1620 Investment Advisors first reported a position in PAHC in Q3 2025 and has held it in 4 quarters since. The position peaked at $37.4K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • 1620 Investment Advisors held 550 shares of Phibro Animal Health worth $17.3K as of Q2 2026.
  • 1620 Investment Advisors sold 126 Phibro Animal Health shares in Q2 2026, an estimated $5.32K.
  • Phibro Animal Health made up 0.01% of 1620 Investment Advisors's portfolio in Q2 2026, its #435 holding.
  • 1620 Investment Advisors first reported a position in Phibro Animal Health in Q3 2025 and has held it in 4 quarters since.
  • 1620 Investment Advisors's Phibro Animal Health position peaked at $37.4K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.